Navigation Links
Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports
Date:7/22/2014

New York, NY (PRWEB) July 22, 2014

A Florida woman has filed a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/ ) that alleges the death of her husband was the result of uncontrollable internal bleeding caused by the blood thinner, Bernstein Liebhard LLP reports. According to her complaint, which was filed in the U.S. District Court for the Southern District of Florida on June 23rd, the decedent began taking Xarelto in January 2012, and suffered a subdural hemorrhage the following June. Despite emergency treatment, his doctors were unable to stop the bleeding, and he died on June 28, 2012. Among other things, the complaint alleges that the manufacturers of the blood thinner did not adequately warn of the irreversible nature of Xarelto bleeding. (Case 0:14-cv-61448-JAL)

“Our Firm has received a number of inquiries from individuals who claim to have experienced Xarelto complications similar to those cited in this lawsuit. We will be monitoring this growing litigation closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering Xarelto case reviews to people who allegedly have suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.

Xarelto Bleeding Allegations
According to the Florida Xarelto lawsuit, the medication is one of a new class of blood thinners known as direct thrombin inhibitors. The drug was launched on the U.S. market in 2011 by Johnson & Johnson and Bayer HealthCare, and was positioned as an improvement over decades-old warfarin. Like all blood thinners, Xarelto can sometimes cause patients to experience internal bleeding. However, while bleeding from warfarin can be stopped via the administration of vitamin K, the lawsuit points out that there is no readily available antidote for Xarelto bleeding.

According to a recent Reuters report, the Florida claim is just one of several lawsuits pending in U.S. courts that involve Xarelto. Bayer and Johnson & Johnson have acknowledged at least 10 such filings. *

Last month, the Institute for Safe Medicine Practices (ISMP) also reported that adverse events associated with the use of Xarelto are on the rise. According to data from the U.S. Food & Drug Administration (FDA), the agency received a total of 680 Xarelto adverse event reports in the first quarter of 2013. For the first time, reports of Xarelto complications outpaced those associated with Pradaxa, another blood thinner in the same class, according to the ISMP.**

Individuals who were allegedly harmed by Xarelto may be entitled to compensation for their injury-related damages, including medical bills, lost wages, pain and suffering, and more. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

*reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, Reuters.com, June 14, 2014.
**ismp.org/quarterwatch/pdfs/2013Q1.pdf, Institute for Safe Medication Practices, May 7, 2014.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.xareltolawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/xarelto-lawsuit/xarelto-bleeding/prweb12037692.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Xarelto Lawsuits Filed Contend Wrongful Death and Internal Hemorrhaging Due to Blood Thinner
2. Bernstein Liebhard LLP Launches New Xarelto Lawsuit Website for Individuals Allegedly Injured by Blood Thinner
3. Xarelto is Alleged to Cause Serious and Uncontrolled Internal Bleeding
4. Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
5. AffordRx Now Offering Xarelto Coupon Cards
6. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
7. Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports
8. Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports
9. DePuy Hip Recall Lawsuits News: 7,000 Plaintiffs Enroll in Settlement Program Since Plan Announced in November, Rottenstein Law Group LLP Reports
10. As Testosterone Treatment Lawsuits Mount, Bernstein Liebhard LLP Notes Scheduling of FDA Meeting to Address Risks Associated with Low Testosterone Therapy
11. Actos Lawsuit Filed by Wright & Schulte LLC Contends NY Man Developed Bladder Cancer after Taking the Type II Diabetes Medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology: